The German drugmaker said the Tyenne approval – its third for a biosimilar after Idacio (adalimumab) and Stimufend (pegfilgrastim) – is a key component of its Vision 2026 strategy aimed at ...

Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...

Amgen's longer-acting version of the drug – Neulasta (pegfilgrastim) – grew 5 per cent to approach $4.4 billion last year. That product could also be under threat, however, as it is due to ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Purpose To develop an evidence-based clinical practice guideline for the prevention of oral mucositis in children (0–18 years) receiving treatment for cancer or undergoing haematopoietic stem cell ...